Takeda Pharmaceutical
TAK
#478
Rank
HK$372.21 B
Marketcap
HK$111.85
Share price
0.81%
Change (1 day)
7.13%
Change (1 year)

Market capitalization of Takeda Pharmaceutical (TAK)

Market cap: HK$372.21 Billion

As of December 2025 Takeda Pharmaceutical has a market cap of HK$372.21 Billion. This makes Takeda Pharmaceutical the world's 478th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Takeda Pharmaceutical from 2008 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$372.21 B13.85%
2024HK$326.91 B-7.09%
2023HK$351.87 B-7.14%
2022HK$378.95 B13.78%
2021HK$333.04 B-24.52%
2020HK$441.26 B-8.57%
2019HK$482.61 B134.93%
2018HK$205.42 B-40.64%
2017HK$346.04 B36.98%
2016HK$252.62 B-17.64%
2015HK$306.73 B19.76%
2014HK$256.11 B-9.02%
2013HK$281.49 B2.61%
2012HK$274.33 B1.46%
2011HK$270.37 B-9.62%
2010HK$299.16 B18.93%
2009HK$251.55 B-28.92%
2008HK$353.90 B

End of Day market cap according to different sources

On Dec 9th, 2025 the market cap of Takeda Pharmaceutical was reported to be:

HK$349.21 Billion
by Nasdaq info icon info icon
HK$369.23 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$3.872 T 940.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$916.58 B 146.25%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
HK$1.140 T 206.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$1.959 T 426.34%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
HK$335.78 B-9.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
HK$90.16 B-75.77%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
HK$1.321 T 255.01%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$760.69 B 104.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
HK$1.897 T 409.78%๐Ÿ‡บ๐Ÿ‡ธ USA